Short Interest in Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) Increases By 342.9%

Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) saw a significant growth in short interest in November. As of November 30th, there was short interest totalling 3,100 shares, a growth of 342.9% from the November 15th total of 700 shares. Based on an average trading volume of 9,000 shares, the short-interest ratio is presently 0.3 days.

Pharma-Bio Serv Stock Performance

Shares of PBSV remained flat at $0.50 during trading hours on Wednesday. The stock has a market cap of $11.48 million, a price-to-earnings ratio of -16.67 and a beta of 0.56. The firm’s 50-day moving average is $0.56 and its 200 day moving average is $0.60. Pharma-Bio Serv has a 12-month low of $0.31 and a 12-month high of $1.09.

Pharma-Bio Serv (OTCMKTS:PBSV) last announced its earnings results on Monday, September 16th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.04). Pharma-Bio Serv had a negative return on equity of 5.81% and a negative net margin of 7.81%. The company had revenue of $2.42 million for the quarter, compared to the consensus estimate of $3.50 million.

Pharma-Bio Serv Company Profile

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.